Aztreonam: Worldwide overview of the treatment of patients with gram-negative infections
- 8 February 1985
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 78 (2) , 57-64
- https://doi.org/10.1016/0002-9343(85)90206-2
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Cefotaxime and Cephalosporins: Adverse Reactions in PerspectiveClinical Infectious Diseases, 1982
- In-vitro antibacterial activity of SQ 26,776Journal of Antimicrobial Chemotherapy, 1981
- Antibacterial activity of the monobactam SQ 26,776 against antibiotic resistant enterobacteria, including Serratia spp.Journal of Antimicrobial Chemotherapy, 1981
- SQ 26,776, a novel -lactam: an in-vitro comparison with other antimicrobial agentsJournal of Antimicrobial Chemotherapy, 1981
- In-vitro activity of the monobactam, SQ 26,776, against Gram-negative bacteria and its stability to their -lactamasesJournal of Antimicrobial Chemotherapy, 1981
- Antibacterial activity of a monocyclic -lactam SQ 26,776Journal of Antimicrobial Chemotherapy, 1981
- Tobramycin Sulfate: A Summary of Worldwide Experience from Clinical TrialsThe Journal of Infectious Diseases, 1976